Related Experiment Video
Updated: Oct 2, 2026

Porcine Corneal Tissue Explant to Study the Efficacy of Herpes Simplex Virus-1 Antivirals
Published on: September 20, 2021
Herpes simplex virus isolates with reduced adefovir susceptibility selected in vivo by foscarnet therapy
Julie Bestman-Smith1, Guy Boivin
1Centre de Recherche en Infectiologie of the Centre Hospitalier Universitaire de Québec (Pavillon CHUL), and Universiteé Laval, Québec, Canada.
Abstract:
Sequential herpes simplex virus (HSV) isolates from AIDS patients receiving foscarnet therapy were evaluated for susceptibility to adefovir. Foscarnet-resistant isolates with DNA polymerase mutations in regions II, VI, and between I and VII were also associated with an important decrease in susceptibility to adefovir (mean IC50 increase: 4.6-fold compared to pre-foscarnet or wild-type isolates) suggesting that adefovir-resistant HSV could be selected in vivo by foscarnet therapy.
Related Concept Videos
Antiviral Nucleoside Inhibitors
Herpes
Genital Herpes
Inhibitors of Viral Protein Synthesis
Retrovirus Life Cycles
Subviral Agents

